The global Clinical Oncology Next Generation Sequencing (NGS) Market was valued at approximately USD 704.70 million in 2023 and is projected to reach USD 1745.02 million by 2032, growing at a CAGR of 10.60%. North America remains a dominant player, with an estimated market size of USD 218.51 million in 2023, growing at a CAGR of 9.09% from 2025 through 2032. Clinical Oncology Next Generation Seq..
